Recent advances in pharmacotherapies for the externalizing disorders

School Psychology Quarterly

Volumn 20, Issue 2, 2005, Pages 118-134

  Brown, Ronald T ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22144470143     PISSN: 10453830     EISSN: None     Source Type: Journal    
DOI: 10.1521/scpq.20.2.118.66515     Document Type: Article

References (54)

1. American Academy of Pediatrics (1985). Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics, 76, 644-647.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Bangs, M. E., Petti, T. A., & Janus, M. D. (1994). Fluoxetine-induced memory impairment in an adolescent. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1303-1306.
4. Barkley, R. A. (1998). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment (2nd ed.). New York: Guilford.
5. Barkley, R. A., Fischer, M., Edelbrock, C. S., & Smallish, L. (1991). The adolescent outcome of hyperactive children diagnosed by research criteria: III. Mother-child interactions, family conflicts and maternal psychopathology. Journal of Child Psychology and Psychiatry, 32, 233-253.
6. Barkley, R. A., Fishcher, M., Smallish, L., & Fletcher, K. (20032). Does the treatment of ADHD with stimulant medication contribute to illicit drug use and abuse in adulthood: Results from a 15-year prospective study. Pediatrics, 111, 97-109.
7. Barrickman, L. L., Peery, P. J., Allen, A. J., & Kuperman, S. (1995). Buproprion versus methylphenidate in the treatment of ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 649-657.
8. Brown, R. T., & La Rosa, A. (2002). Recent developments in the pharmacotherapy of attention-deficit/hyperactivity disorder. Professional Psychology: Research and Practice, 33, 591-595.
9. Brown, R. T., Perwien, A., Faries, D. E., Kratochvil, C. J., & Vaughan, B. S. (2004). Atomoxetine in the management of children with ADHD: Effects on quality of life and school functioning. Unpublished manuscript. Temple University.
10. Brown, R. T., & Sammons, M. T. (2002). Pediatric psychopharmacology: A review of new developments and recent research. Professional Psychology: Research and Practice, 33, 135-147.
11. Buhrmester, D., Whalen, C. K., Henker, B., McDonald, V., & Hinshaw, S. P. (1992). Prosocial behavior in hyperactive boys: Effects of stimulant medication and comparison with normal boys. Journal of Abnormal Child Psychology, 20, 103-121.
12. Campbell, S. B. (1990). Behavior problems in preschool children. New York: Guilford.
13. Campbell, M., Small, A. M., Green, W.H., Jennings, S. J., Perry, R., Bennett, W. G., & Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Archives of General Psychiatry, 41, 650-656.
14. Campbell, M., Gonzalez, N. M., & Silva, R. R. (1992). The pharmacologic treatment of conduct disorders and rage outbursts. Psychiatric Clinics of North America, 15, 103-121.
15. Campbell, M., Kafantaris, V., & Cueva, J. E. (1995). An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorders. Psychopharmacology Bulletin, 31, 93-102.
16. Conners, C. K., Epstein, J. N., & March, J. S. (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 159-167.
17. Fox, M. H., Foster, C. H., & Zito, J. M. (2000). Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in Medicaid. American Journal of Medical Quality, 15, 123-136.
18. Gadow, K. D. (1999). Prevalence of drug therapy. In J. S. Werry & M. G. Aman (Eds.), Practi tioner's guide to psychoactive drugs for children and adolescents (2nd ed, pp. 3-22). New York: Plenum.
19. Geller, B., Cooper, T. B., Sun, K., Zimerman, B., Frazier, J., Williams, M. et al. (1998). Double-blind placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 171-178.
20. Geller, B., Reising, D., Leonard, H. L., Riddle, M. A., & Walsh, B.T. (1999). Critical review of tricyclic antidepressant use in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 513-516.
21. Giedd, J. N., Castellanos, F. X., Casey, B. J., Kozuch, P., King, A. C., Hamburger, S. D., & Rapoport, J. L. (1994). Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. American Journal of Psychiatry, 151, 665-669.
22. Hinshaw, S. P. (1991). Stimulant medication and the management of aggression in children with attentional deficits. Journal of Clinical Child Psychology, 20, 301-312.
23. Hinshaw, S. P. (2000). Family processes and treatment outcomes in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Child Psychology, 28, 555-568.
24. Hinshaw, S. P., & Lee, S. S. (2003). Conduct and oppositional defiant disorders. In E. J. Mash & & & R.A. Barkley (Eds.), Child psychopathology (2nd ed., pp. 144-198). New York: Guilford.
25. Hinshaw, S. P., Owens, E. B., & Wells, K. C. (2000). Family process and treatment outcomes in the MTA: Negative/ineffective parenting practice in relation to multimodal treatment. Journal of Abnormal Child Psychology, 28, 555-568.
26. Jensen, P. S., Kettle, L., Roper, M. T., Sloan, M. T., Dulcan, M. K., Hoven, C., et al. (1999). Are stimulants over-prescribed? Treatment of ADHD in four U.S. communities. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 797-804.
27. Jensen, P. S., Hinshaw, S. P., & Kraemer, H. C. (2001). ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 147-158.
28. Kaplan, S. L., Busner, J., Kupietz, S., Wasserman, E., & Segal, B. (1990). Effects of methylphenidate on adolescents with aggressive conduct disorder and ADHD: A preliminary report. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 719-723.
29. Kazdin, A. E. (1987). Treatment of antisocial behavior in children: Current status and future directions. Psychological Bulletin, 102, 187-203.
30. Klein, R. G., & Mannuzza, S. (1988). Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Archives of General Psychiatry, 45, 1131-1134.
31. Kratochvil, C. J., Vaughan, B. S., Harrington, M. J., & Burke, W. J. (2003). Atomoxetine: A selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder. Experimental Pharmacotherapeutics, 4, 1165-1174.
32. Kratochvil, C. J., Heilgenstein, J. H., & Dittman, R. (2002). Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 776-784.
33. Kubiszyn, T., Carlson, J. S., & DeHay, T (this issue). Pediatric psychopharmacology for prepubertal internalizing disorders. School Psychology Quarterly, 20, 135-154.
34. Lahey, B. B., & Loeber, R. (1994). Framework for a developmental model of oppositional defiant disorder and conduct disorder. In D.K. Routh (Ed.), Disruptive behavior disorders in childhood (pp. 139-180). New York: Plenum Press.
35. Lahey, B. B., Loeber, R., Quay, H. C., Frick, P. J., & Grimm, S. (1992). Oppositional defiant and conduct disorders: Issues to be resolved for DSM-IV. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 539-546.
36. Michelson, D., Allen, A. J., & Busner, J. (2002). Once daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896-1901.
37. Michelson, D., Faries, D., & Wernicke, J. (2001). Atomoxetine in the treatment of children and ado lescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics, 108, e83.
38. Multimodal Treatment study of Children with ADHD ADHD (MTA) Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity ddisorder. Archives of General Psychiatry, 56, 1073-1086.
39. MTA Cooperative Group (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762-769.
40. Pelham, W. E., Jr., Gnagy, E. M., Greiner, A. R., Hoza, B., Hinshaw, S. P., Swanson, J. M., et al. (2000). Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology, 28, 507-525.
41. Phelps, L., Brown, R. T., & Power, T. (2001). Pediatric psychopharmacology: Combining medical and psychosocial intervention. Washington, DC: American Psychological Association.
42. Pliszka, S. R. (1991). Antidepressants in the treatment of child and adolescent psychopathology. Journal of Clinical Child Psychology, 20, 313-320.
43. Pleak, R. R., Birmaher, B., Gavrilescu, A., Abichandani, C., & Williams, D. T. (1988). Mania and neuropsychiatric excitation following carbamazapine. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 127-132.
44. Prochaska, J. O., DiClemente, C. C., & Norcross, J. C. (1992). In search of how people change: Applications to addictive behavior. American Psychologist, 47, 1101-1114.
45. Rifkin, A., Karajgi, B., Dicker, R., Perl, E., Boppana, V., Hasan, N., & Pollack, S. (1997). Lithium treatment of conduct disorders in adolescents. American Journal of Psychiatry, 154, 554-555.
46. Silver, A. A., Shytle, R. D., Sheehan, K. H., Sheehan, D. V., Ramos, A., & Sanberg, P. R. (2001). Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's distorder. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 1103-1110.
47. Taylor, E. (1999). Development of clinical services for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1097-1099.
48. Vining, E., Carpenter, R. O., & Aman, M. G. (1999). Antiepileptics (anticonvulsants). In J. Werry & M. Aman (Eds.), Practitioner's guide to psychoactive drugs for children and adolescents (2nd ed., pp. 355-385). New York: Plenum.
49. Vitiello, B. (2001). Psychopharmacology for young children: Clinical needs and research opportunities. Pediatrics, 108, 983-989.
50. Wells, K. C., Epstein, J. N., & Hinshaw, S. P. (2000). Parenting and family stress treatment outcome in attention-deficit hyperactivity disorder (ADHD): An empirical analysis in the MTA study. Journal of Abnormal Child Psychology, 28, 543-553.
51. Werry, J. S., & Aman, M. G. (1999). Practitioner's guide to psychoactive drugs for children and adolescents (2nd ed.). New York: Plenum Press.
52. Young, J. M., Shytle, R. D., Sanberg, P. R., & George, T. P. (2001). Mecamylamine: New therapeutic uses and toxicity/risk profile. Clinical Therapeutics, 23, 532-565.
53. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000). Trends in the pPrescribing of psychoactive medications to preschoolers. Journal of the American Medical Association, 283, 1025-1030.
54. Zito, J. M., Safer, D. J., dos Reis, S., Gardner, J. F., Magder, L., Socken, K. et al. (2003). Psychotropic practice patterns for youth. Archives of Pediatrics and Adolescent Medicine, 157, 17-25.